Carglumic acid
Template:Short description Template:Main other <templatestyles src="Infobox drug/styles.css"/> Script error: No such module "Infobox".Template:Template otherScript error: No such module "TemplatePar".{{Infobox drug/maintenance categoriesTemplate:Yesno | drug_name = | INN = | _drugtype =
| _has_physiological_data= | _has_gene_therapy=
| vaccine_type= | mab_type= | _number_of_combo_chemicals=Script error: No such module "ParameterCount". | _vaccine_data= | _mab_data= | _mab_vaccine_data= | _mab_other_data=61025C(CC(=O)O)[C@@H](C(=O)O)NC(=O)N1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1LCQLHJZYVOQKHU-VKHMYHEASA-NTemplate:StdinchiciteTemplate:Stdinchicite | _combo_data= | _physiological_data= | _clinical_data=Template:Drugs.comCarglumic acid B1By mouthCarbaglu, UcedaneA16 | _legal_data=[1]S4[2]Rx-only[3][4]Rx-only[5]Rx-only
| _other_data=(2S)-2-(carbamoylamino)pentanedioic acid
| _image_0_or_2 = Carglumic acid.svg | _image_LR =
| _datapage = Carglumic acid (data page) | _vaccine_target=_type_not_vaccine | _legal_all=S4Rx-onlyRx-onlyRx-only | _ATC_prefix_supplemental=A16 | _has_EMA_link = | CAS_number=1188-38-1 | PubChem=121396 | ChemSpiderID=1265942 | ChEBI=71028 | ChEMBL=1201780 | DrugBank=DB06775 | KEGG=D07130 | _hasInChI_or_Key=yes | UNII=5L0HB4V1EW | _hasJmol02 = |_hasMultipleCASnumbers = |_hasMultiplePubChemCIDs = |_hasMultipleChEBIs =
| _countSecondIDs=Script error: No such module "ParameterCount". | _countIndexlabels=Script error: No such module "ParameterCount". | _trackListSortletter= |QID = |QID2 = |Verifiedfields=changed |Watchedfields= |verifiedrevid=460019355}}
Carglumic acid, sold under the brand name Carbaglu among others, is used for the treatment of hyperammonaemia.[5][6][7] Carglumic acid is a carbamoyl phosphate synthetase 1 (CPS 1) activator.[5]
The most common adverse effects include vomiting, abdominal pain, pyrexia (fever), and tonsillitis, anemia, diarrhea, ear infection, other infections, nasopharyngitis, decreased hemoglobin levels, and headache.[5]
It was approved for medical use in the United States in March 2010.[8] Carglumic acid is an orphan drug.[9][10] It is available as a generic medication.[11]
Medical uses
Carglumic acid is indicated for the treatment of acute hyperammonemia and chronic hyperammonemia.[5][3][4]
References
Template:Other alimentary tract and metabolism products Template:Portal bar
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ a b c d e Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "citation/CS1".